UZ Leuven

Gastroenterology and Inflammatory Bowel Disease

Research activity includes Crohn’s disease, acute severe ulcerative colitis, pouchitis, short bowel syndrome, irritable bowel syndrome, functional dyspepsia, gastro-oesophageal reflux disease, and opioid-induced constipation.

  • Inflammatory bowel disease surgery and recurrence
  • Intestinal motility and upper gastrointestinal symptoms
  • Supportive care in gastrointestinal disorders

Additional work spans infliximab treatment strategies, proton pump inhibitor deprescribing, and symptom-focused care in chronic digestive disease.

Oncology and Hematologic Malignancy

The oncology portfolio covers gastro-esophageal adenocarcinoma, pancreatic ductal adenocarcinoma, colorectal cancer, rectal cancer, breast cancer, prostate cancer, ovarian cancer, and malignant melanoma.

  • Targeted treatment in receptor-defined cancers
  • Metastasis-directed approaches in advanced solid tumors
  • Perioperative and neoadjuvant cancer care

Studies also address febrile neutropenia, tumor imaging with PET/CT, and treatment selection in clinically challenging oncologic settings.

Neurology, Neurodegeneration, and Developmental Disorders

Clinical research includes Alzheimer disease, frontotemporal dementia, Lewy body disease, Parkinson’s disease, multiple system atrophy, amyotrophic lateral sclerosis, spinal muscular atrophy, autism spectrum disorder, cerebral palsy, traumatic brain injury, and drug-resistant epilepsy.

  • Neurodegenerative disease characterization
  • Motor and cognitive outcome assessment
  • Pediatric neurodevelopmental care

Imaging and biomarker work extends to tau pathology, carotid atherosclerosis, and functional brain circuit studies.

Rheumatology, Dermatology, and Immune-Mediated Disease

Studies focus on rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, giant cell arteritis, IgG4-related disease, hidradenitis suppurativa, chronic rhinosinusitis with nasal polyps, and nonsteroidal anti-inflammatory drug-exacerbated respiratory disease.

  • Biologic and targeted immune therapy
  • Vasculitis and inflammatory airway disease
  • Inflammatory skin and joint disorders

Research also addresses dupilumab, rituximab, tofacitinib, and anti-TNF strategies in immune-mediated conditions.

Perioperative Care, Critical Care, and Clinical Pharmacology

Trials span infective endocarditis, severe community-acquired pneumonia, prosthetic joint infections, fracture-related infections, cardiac surgery, obstetric and fetal surgery, and intensive care management in critically ill patients.

  • Antimicrobial treatment optimization
  • Perioperative analgesia and anesthesia
  • Drug exposure and pharmacokinetics in complex care

Additional interests include ceftazidime-avibactam, clindamycin, apixaban, ketamine, oxytocin, and naloxegol.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Optimizing Ceftazidime-Avibactam Dosing for Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Spain Sweden
  • Study on the Effects of Rikkunshito on Functional Dyspepsia in Primary Care Patients

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium
  • Study on Botulinum Toxin Type A for Treating Spastic Equinovarus in First-Time Stroke Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium
  • Study on Oxytocin Treatment for Children with Autism and Intellectual Disability

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium
  • Study of [18F]AlF-NOTA-Octreotide for Carotid Artery Disease in Patients with Recent Stroke or TIA

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium
  • Study on the Effects of Ketamine on Therapy Intensity and Brain Pressure in Patients with Traumatic Brain Injury

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium